144 results on '"Buján, Julia"'
Search Results
2. Vascular Calcification: Molecular Networking, Pathological Implications and Translational Opportunities.
- Author
-
Ortega, Miguel A., De Leon-Oliva, Diego, Gimeno-Longas, Maria José, Boaru, Diego Liviu, Fraile-Martinez, Oscar, García-Montero, Cielo, de Castro, Amador Velazquez, Barrena-Blázquez, Silvestra, López-González, Laura, Amor, Silvia, García-Honduvilla, Natalio, Buján, Julia, Guijarro, Luis G., Castillo-Ruiz, Elisa, Álvarez-Mon, Miguel Ángel, Albillos, Agustin, Álvarez-Mon, Melchor, Diaz, Raul, and Saez, Miguel A.
- Subjects
ARTERIAL calcification ,PERICYTES ,NOTCH genes ,VASCULAR smooth muscle ,CELL anatomy ,PERIPHERAL vascular diseases ,MUSCLE cells - Abstract
Calcification is a process of accumulation of calcium in tissues and deposition of calcium salts by the crystallization of PO
4 3− and ionized calcium (Ca2+ ). It is a crucial process in the development of bones and teeth. However, pathological calcification can occur in almost any soft tissue of the organism. The better studied is vascular calcification, where calcium salts can accumulate in the intima or medial layer or in aortic valves, and it is associated with higher mortality and cardiovascular events, including myocardial infarction, stroke, aortic and peripheral artery disease (PAD), and diabetes or chronic kidney disease (CKD), among others. The process involves an intricate interplay of different cellular components, endothelial cells (ECs), vascular smooth muscle cells (VSMCs), fibroblasts, and pericytes, concurrent with the activation of several signaling pathways, calcium, Wnt, BMP/Smad, and Notch, and the regulation by different molecular mediators, growth factors (GFs), osteogenic factors and matrix vesicles (MVs). In the present review, we aim to explore the cellular players, molecular pathways, biomarkers, and clinical treatment strategies associated with vascular calcification to provide a current and comprehensive overview of the topic. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
3. 3D silicon doped hydroxyapatite scaffolds decorated with Elastin-like Recombinamers for bone regenerative medicine
- Author
-
Vila, Mercedes, García, Ana, Girotti, Alessandra, Alonso, Matilde, Rodríguez-Cabello, Jose Carlos, González-Vázquez, Arlyng, Planell, Josep A., Engel, Elisabeth, Buján, Julia, García-Honduvilla, Natalio, and Vallet-Regí, María
- Published
- 2016
- Full Text
- View/download PDF
4. Bioactive bilayered dressing for compromised epidermal tissue regeneration with sequential activity of complementary agents
- Author
-
Reyes-Ortega, Felisa, Cifuentes, Alberto, Rodríguez, Gema, Aguilar, María Rosa, González-Gómez, Álvaro, Solis, Raul, García-Honduvilla, Natalio, Buján, Julia, García-Sanmartin, Josune, Martínez, Alfredo, and Román, Julio San
- Published
- 2015
- Full Text
- View/download PDF
5. Effects of a novel NADPH oxidase inhibitor (S42909) on wound healing in an experimental ischemic excisional skin model
- Author
-
Sotomayor, Sandra, Pascual, Gemma, Blanc‐Guillemaud, Vanessa, Mesa‐Ciller, Claudia, García‐Honduvilla, Natalio, Cifuentes, Alberto, and Buján, Julia
- Published
- 2017
- Full Text
- View/download PDF
6. Venous Wall of Patients with Chronic Venous Disease Exhibits a Glycolytic Phenotype.
- Author
-
Fraile-Martinez, Oscar, García-Montero, Cielo, Alvarez-Mon, Miguel Ángel, Gomez-Lahoz, Ana M., Monserrat, Jorge, Llavero-Valero, Maria, Ruiz-Grande, Fernando, Coca, Santiago, Alvarez-Mon, Melchor, Buján, Julia, García-Honduvilla, Natalio, Saz, Jose V., and Ortega, Miguel A.
- Subjects
CHRONICALLY ill ,PHENOTYPES ,VARICOSE veins ,GLUCOSE transporters ,PROTEIN expression - Abstract
Chronic venous disease (CVeD) is a rising medical condition characterized by a broad spectrum of disorders in the venous system. Varicose veins (VVs) represent a frequent clinical manifestation of CVeD, particularly in the lower limbs. Prior histopathological studies have defined a set of alterations observed in the venous wall of patients with VVs, affecting their structure and behavior. Metabolic changes in the veins appear to be a critical biological mechanism aiding our understanding of the pathogenesis of CVeD. In this sense, previous studies have identified a potential role of a glycolytic phenotype in the development of different vascular disorders; however, its precise role in CVeD remains to be fully explored. Thus, the aim of the present study was to analyze the gene and protein expression of glucose transporter 1 (GLUT-1) and the glycolytic enzymes PGK-1, ALD, GA3PDH and LDH in the VVs of patients with CVeD (n = 35) in comparison to those expressed in healthy subjects. Our results display enhanced gene and protein expression of GLUT-1, PGK-1, ALD, GA3PDH and LDH in patients with CVeD, suggesting a glycolytic switch of the venous tissue. Greater understanding of the impact of this glycolytic switch in patients with CVeD is required to define a possible pathophysiological role or therapeutic implications of these changes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Clinical and Novel Biomarkers in Penile Carcinoma: A Prospective Review.
- Author
-
Pekarek, Leonel, Ortega, Miguel A., Fraile-Martinez, Oscar, García-Montero, Cielo, Casanova, Carlos, Saez, Miguel A., García-Honduvilla, Natalio, Alvarez-Mon, Melchor, Buján, Julia, Diez-Nicolas, Victor, Burgos, Javier F., and Gomez Dos Santos, Victoria
- Subjects
PENILE cancer ,PROSTATE ,MALE reproductive organs ,PAPILLOMAVIRUSES ,OLDER men ,OLDER patients ,BIOMARKERS ,PENIS - Abstract
Penile carcinoma is a rare urological neoplasia in men compared to other more common tumors, such as prostate, kidney, or bladder tumors. However, this neoplasm continues to affect a large number of patients worldwide, with developing countries presenting the highest incidence and mortality rates. Important risk factors such as the human papilloma virus, a factor affecting a large number of patients, have been described; however, few studies have evaluated screening programs in populations at risk for this disease, which severely affects the quality of life of older men. The management of these patients is usually complex, requiring surgical interventions that are not without risk and that have a great impact on the functionality of the male reproductive system. In addition, in cases of disseminated disease or with significant locoregional involvement, patients are evaluated by multidisciplinary oncological committees that can adjust the application of aggressive neoadjuvant or adjuvant chemotherapy on numerous occasions without clear improvement in survival. Chemotherapy regimens are usually aggressive, and unlike in other urological neoplasms, few advances have been made in the use of immunotherapy in these patients. The study of serological and histological biomarkers may help to better understand the underlying pathophysiology of these tumors and select patients who have a higher risk of metastatic progression. Similarly, the analysis of molecular markers will improve the availability of targeted therapies for the management of patients with disseminated disease that would benefit prognosis. Therefore, the purpose of this article is to summarize the main advances that have occurred in the development of serological and histological markers and their therapeutic implications in patients diagnosed with penile carcinoma, explaining the limitations that have been observed and analyzing future perspectives in the management of this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma—A Histopathological Study.
- Author
-
Ortega, Miguel A., Fraile-Martinez, Oscar, García-Montero, Cielo, Borja-Vergel, Sandra, Torres-Carranza, Diego, Pekarek, Leonel, Arribas, Coral Bravo, De León-Luis, Juan A., Sánchez-Rojo, Cristina, Alvarez-Mon, Miguel Angel, García-Honduvilla, Natalio, Buján, Julia, Coca, Santiago, Alvarez-Mon, Melchor, Saez, Miguel A., and Guijarro, Luis G.
- Subjects
LOBULAR carcinoma ,DUCTAL carcinoma ,CYCLOOXYGENASE 2 ,RETINOBLASTOMA protein ,INSULIN receptors ,CANCER-related mortality - Abstract
Background and Objectives: Breast cancer (BC) is the first diagnosed type of cancer and the second leading cause of cancer-related mortality in women. In addition, despite the improvement in treatment and survival in these patients, the global prevalence and incidence of this cancer are rising, and its mortality may be different according to the histological subtype. Invasive lobular carcinoma (ILC) is less common but entails a poorer prognosis than infiltrative ductal carcinoma (IDC), exhibiting a different clinical and histopathological profile. Deepening study on the molecular profile of both types of cancer may be of great aid to understand the carcinogenesis and progression of BC. In this sense, the aim of the present study was to explore the histological expression of Insulin receptor substrate 4 (IRS-4), cyclooxygenase 2 (COX-2), Cyclin D1 and retinoblastoma protein 1 (Rb1) in patients with ILC and IDC. Patients and Methods: Thus, breast tissue samples from 45 patients with ILC and from 45 subjects with IDC were analyzed in our study. Results: Interestingly, we observed that IRS-4, COX-2, Rb1 and Cyclin D1 were overexpressed in patients with ILC in comparison to IDC. Conclusions: These results may indicate a differential molecular profile between both types of tumors, which may explain the clinical differences among ILC and IDC. Further studies are warranted in order to shed light onto the molecular and translational implications of these components, also aiding to develop a possible targeted therapy to improve the clinical management of these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer.
- Author
-
Pekarek, Leonel, Fraile-Martinez, Oscar, Garcia-Montero, Cielo, Saez, Miguel A., Barquero-Pozanco, Ines, del Hierro-Marlasca, Laura, de Castro Martinez, Patricia, Romero-Bazán, Adoración, Alvarez-Mon, Miguel A., Monserrat, Jorge, García-Honduvilla, Natalio, Buján, Julia, Alvarez-Mon, Melchor, Guijarro, Luis G., and Ortega, Miguel A.
- Subjects
PANCREATIC tumors ,IMMUNOHISTOCHEMISTRY ,EARLY detection of cancer ,CANCER relapse ,TUMOR markers - Abstract
Simple Summary: Pancreatic cancer is one of the most heterogeneous and aggressive tumours that exist. The median survival of diagnosed patients is limited. For all these reasons, it is necessary to develop new disease markers that allow guidelines for clinical action to improve the average survival of patients with pancreatic cancer. The incidence and prevalence of pancreatic adenocarcinoma have increased in recent years. Pancreatic cancer is the seventh leading cause of cancer death, but it is projected to become the second leading cause of cancer-related mortality by 2040. Most patients are diagnosed in an advanced stage of the disease, with very limited 5-year survival. The discovery of different tissue markers has elucidated the underlying pathophysiology of pancreatic adenocarcinoma and allowed stratification of patient risk at different stages and assessment of tumour recurrence. Due to the invasive capacity of this tumour and the absence of screening markers, new immunohistochemical and serological markers may be used as prognostic markers for recurrence and in the study of possible new therapeutic targets because the survival of these patients is low in most cases. The present article reviews the currently used main histopathological and serological markers and discusses the main characteristics of markers under development. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies.
- Author
-
Ortega, Miguel A., Pekarek, Leonel, Fraile-Martinez, Oscar, Garcia-Montero, Cielo, Saez, Miguel A., Asúnsolo, Angel, Alvarez-Mon, Miguel A., Monserrat, Jorge, Ruiz-Llorente, Lidia, García-Honduvilla, Natalio, Albillos, Agustin, Buján, Julia, Alvarez-Mon, Melchor, and Guijarro, Luis G.
- Subjects
PANCREATIC cancer ,LUNG cancer ,CANCER chemotherapy ,IMMUNOTHERAPY ,BIOMARKERS - Abstract
Pancreatic cancer will be positioned by the year 2030 as the second cause of oncological death after lung cancer. The pathophysiology of the most common variety, which involves the adenocarcinoma of the pancreas, represents one of the main challenges for current oncology to explain its tumorigenesis and create a targeted treatment. The tumor microenvironment, metastatic capacity, and lack of early diagnosis lead patients to present advanced stages at the time of diagnosis. Despite numerous efforts, little progress has been made in clinical outcomes and with respect to the improved survival of these patients. For this reason, in recent years, numerous diagnostic tests, treatments, and possible approaches in the fields of radiotherapy, chemotherapy, immunotherapy, and surgery have been developed to find a combination of methods that improves life expectancy in patients diagnosed with this disease. On the other hand, the scientific community has made numerous advances in the molecular bases of pancreatic cancer since several oncogenetic pathways have been described and the markers expressed by the tumor have proven to be useful in the prognosis of pancreatic adenocarcinoma. These molecular alterations allow the study of possible therapeutic targets that improve the prognosis of these patients, but even numerous tumor cell-individual interactions must be explained to understand the underlying pathophysiology causing the high mortality. Therefore, the purpose of our study is to examine the expression of markers such as EGFR, Cyclin D1, andCDK4 in order to find a relationship with the possible long-term prognostic factors of patients affected by pancreatic ductal adenocarcinoma. Our results show that there is a prognostic role for ErbB2, EGFR, beta catenin, cyclin D1, and CDK4. Of these, we highlight the clinical importance of ErbB2 in the survival rates of patients who overexpress this component. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer.
- Author
-
Ortega, Miguel A., Fraile-Martinez, Oscar, Pekarek, Leonel, García-Montero, Cielo, Alvarez-Mon, Miguel Angel, Castellanos, Alejandro J., García-Honduvilla, Natalio, Buján, Julia, Alvarez-Mon, Melchor, Sáez, Miguel A., Guijarro, Luis G., and Asúnsolo, Angel
- Subjects
CANCER prognosis ,SURVIVAL rate ,OXIDATIVE stress ,BREAST cancer prognosis ,PROGNOSIS ,PANCREATIC cancer ,MOLECULAR pathology - Abstract
Pancreatic cancer is a malignancy of rising prevalence, especially in developed countries where dietary patterns and sedentariness favor its onset. This malady ranks seventh in cancer-related deaths in the world, although it is expected to rank second in the coming years, behind lung cancer. The low survival rate is due to the asymptomatic course of the early stages, which in many cases leads to metastases when becoming evident in advanced stages. In this context, molecular pathology is on the way towards finding new approaches with biomarkers that allow a better prognosis and monitoring of patients. So the present study aims to evaluate a series of molecular biomarkers, PARP1, NOX1, NOX2, eNOS and iNOS, as promising candidates for prognosis and survival by using immunohistochemistry. The analysis performed in 41 patients with pancreatic cancer showed a correlation between a high expression of all these components with a low survival rate, with high statistical power for all. In addition, a 60-month longitudinal surveillance program was managed, accompanied by several clinical parameters. The derivative Kaplan–Meier curves indicated a low cumulative survival rate as well. Ultimately, our research emphasized the value of these molecules as survival-associated biomarkers in pancreatic cancer, offering new gates for clinical management. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR
- Author
-
Ortega, Miguel A., Fraile-Martínez, Oscar, Asúnsolo, Ángel, Buján, Julia, García-Honduvilla, Natalio, and Coca, Santiago
- Subjects
Article Subject - Abstract
Breast cancer is the cancer with the highest prevalence in women and is the number-one cause of cancer mortality worldwide. Cell transduction is a fundamental process in the development and progression of cancer. Modifications in various cell signalling pathways promote tumour cell proliferation, progression, and survival. The PI3K/Akt/mTOR pathway is an example of that, and it is involved in growth, proliferation, survival, motility, metabolism, and immune response regulation. Activation of this pathway is one of the main causes of cancer cell resistance to antitumour therapies. This makes PI3K/Akt/mTOR signalling a crucial object of study for understanding the development and progression of this disease. Thus, this pathway may have a role as a potential therapeutic target, as well as prognostic and diagnostic value, in patients with breast cancer. Despite the existence of selective PI3K/Akt/mTOR pathway inhibitors and current clinical trials, the cellular mechanisms are not yet known. The present review aims to understand the current state of this important disease and the paths that must be forged.
- Published
- 2020
- Full Text
- View/download PDF
13. Mesenchymal adipose stem cells maintain the capacity for differentiation and survival in culture beyond the long term.
- Author
-
Trejo-Iriarte, Cynthia G, Ortega, Miguel A, Asúnsolo, Ángel, Gómez-Clavel, José F, Muñoz, Alejandro García, Mon, Melchor Álvarez-, Buján, Julia, Acero, Julio, and García-Honduvilla, Natalio
- Subjects
MESENCHYMAL stem cells ,REVERSE transcriptase polymerase chain reaction ,CONNECTIVE tissue cells ,CELL survival ,CELL culture ,CELL differentiation - Abstract
Mesenchymal cells (MSCs) are considered to be cellular populations of common embryological origin. For clinical research applications, MSCs are expanded and increased with cells obtained from a primary culture. By extracting cells from tissue and encouraging them to reproduce, the stem cell population ends up dominating the culture due to a high proliferation rate and self-renewal. The first subcultures between the third and sixth are chosen in order to obtain the maximum number of cells with optimal differentiation capacity. However, few studies have reported long-term cultivation of MSCs. The objective of this study was to advance the knowledge on the characteristics of MSCs by assessing their capacity for self-renewal and phenotypic maintenance beyond 50 cell subcultures, which is defined as the normal limit for cellular survival. Rat subcutaneous adipose tissue was the source of mesenchymal adipose stem cells (MASCs) cultured over 175 subcultures. Early 1 to 5 and late 25 to 30 subcultures were used to induce cellular differentiation to become adipogenic, chondrogenic and osteogenic connective tissue cells. MASCs characteristics were studied using flow cytometry, transmission electron microscopy (TEM), and immunohistochemical and reverse transcription polymerase chain reaction (RT-qPCR) assays. The MASCs maintained cell differentiation capacity for more than 30 subcultures but lost potentiality starting at 60 up to 175 subcultures. MASCs showed the embryonic phenotypes OCT3/4 and Nanog indefinitely, and developed compensatory mechanisms, such as autophagy, to achieve cell survival over a long time period. Therefore, long-term subcultures showed that MASCs could maintain their potential for clinical research use. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Chronic venous disease patients show increased IRS-4 expression in the great saphenous vein wall.
- Author
-
Ortega, Miguel A, Fraile-Martínez, Oscar, García-Montero, Cielo, Ruiz-Grande, Fernando, Barrena, Silve, Montoya, Hector, Pekarek, Leonel, Zoullas, Sofia, Alvarez-Mon, Miguel A, Sainz, Felipe, Asúnsolo, Angel, Acero, Julio, Álvarez-Mon, Melchor, Buján, Julia, García-Honduvilla, Natalio, and Guijarro, Luis G
- Published
- 2021
- Full Text
- View/download PDF
15. Tissue remodelling and increased DNA damage in patients with incompetent valves in chronic venous insufficiency.
- Author
-
Ortega, Miguel A., Fraile‐Martínez, Oscar, García‐Montero, Cielo, Pekarek, Leonel, Alvarez‐Mon, Miguel A., Guijarro, Luis G., del Carmen Boyano, Maria, Sainz, Felipe, Álvarez‐Mon, Melchor, Buján, Julia, García‐Honduvilla, Natalio, and Asúnsolo, Ángel
- Subjects
VENOUS insufficiency ,DNA damage ,TISSUE remodeling ,VALVES ,AGE groups ,MITRAL valve ,SAPHENOUS vein - Abstract
Chronic venous insufficiency (CVI), in which blood return to the heart is impaired, is a prevalent condition worldwide. Valve incompetence is a complication of CVI that results in blood reflux, thereby aggravating venous hypertension. While CVI has a complex course and is known to produce alterations in the vein wall, the underlying pathological mechanisms remain unclear. This study examined the presence of DNA damage, pro‐inflammatory cytokines and extracellular matrix remodelling in CVI‐related valve incompetence. One hundred and ten patients with CVI were reviewed and divided into four groups according to age (<50 and ≥50 years) and a clinical diagnosis of venous reflux indicating venous system valve incompetence (R) (n = 81) or no reflux (NR) (n = 29). In vein specimens (greater saphenous vein) from each group, PARP, IL‐17, COL‐I, COL‐III, MMP‐2 and TIMP‐2 expression levels were determined by RT‐qPCR and immunohistochemistry. The younger patients with valve incompetence showed significantly higher PARP, IL‐17, COL‐I, COL‐III, MMP‐2 and reduced TIMP‐2 expression levels and a higher COL‐I/III ratio. Young CVI patients with venous reflux suffer chronic DNA damage, with consequences at both the local tissue and systemic levels, possibly associated with ageing. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Mouse Models for Human Skin Transplantation: A Systematic Review.
- Author
-
Cristóbal, Lara, Asúnsolo, Ángel, Sánchez, Jorge, Ortega, Miguel A., Álvarez-Mon, Melchor, García-Honduvilla, Natalio, Buján, Julia, and Maldonado, Andrés A.
- Subjects
LABORATORY mice ,SKIN grafting ,GRAFT rejection ,SKIN physiology ,WOUND healing - Abstract
Immunodeficient mouse models with human skin xenografts have been developed in the past decades to study different conditions of the skin. Features such as follow-up period and size of the graft are of different relevance depending on the purpose of an investigation. The aim of this study is to analyze the different mouse models grafted with human skin. A systematic review of the literature was performed in line with the PRISMA statement using MEDLINE/PubMed databases from January 1970 to June 2020. Articles describing human skin grafted onto mice were included. Animal models other than mice, skin substitutes, bioengineered skin, postmortem or fetal skin, and duplicated studies were excluded. The mouse strain, origin of human skin, graft dimensions, follow-up of the skin graft, and goals of the study were analyzed. Ninety-one models were included in the final review. Five different applications were found: physiology of the skin (25 models, mean human skin graft size 1.43 cm
2 and follow-up 72.92 days), immunology and graft rejection (17 models, mean human skin graft size 1.34 cm2 and follow-up 86 days), carcinogenesis (9 models, mean human skin graft size 1.98 cm2 and follow-up 253 days), skin diseases (25 models, mean human skin graft size 1.55 cm2 and follow-up 86.48 days), and would healing/scars (15 models, mean human skin graft size 2.54 cm2 and follow-up 129 days). The follow-up period was longer in carcinogenesis models (253 ± 233.73 days), and the skin graft size was bigger in wound healing applications (2.54 ± 3.08 cm2 ). Depending on the research application, different models are suggested. Careful consideration regarding graft size, follow-up, immunosuppression, and costs should be analyzed and compared before choosing any of these mouse models. To our knowledge, this is the first systematic review of mouse models with human skin transplantation. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
17. Histopathological study of JNK in venous wall of patients with chronic venous insufficiency related to osteogenesis process.
- Author
-
Ortega, Miguel A., Asúnsolo, Ángel, Pekarek, Leonel, Alvarez-Mon, Miguel A., Delforge, Arnaud, Sáez, Miguel A., Coca, Santiago, Sainz, Felipe, Álvarez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Published
- 2021
- Full Text
- View/download PDF
18. Chronic Venous Disease Patients Showed Altered Expression of IGF-1/PAPP-A/STC-2 Axis in the Vein Wall.
- Author
-
Ortega, Miguel A., Fraile-Martínez, Oscar, Asúnsolo, Ángel, Martínez-Vivero, Clara, Pekarek, Leonel, Coca, Santiago, Guijarro, Luis G., Álvarez-Mon, Melchor, Buján, Julia, García-Honduvilla, Natalio, and Sainz, Felipe
- Subjects
CHI-squared test ,CHRONIC diseases ,STATISTICAL correlation ,GENE expression ,IMMUNOHISTOCHEMISTRY ,VEINS ,VENOUS insufficiency ,CROSS-sectional method ,DESCRIPTIVE statistics ,MANN Whitney U Test - Abstract
Chronic venous disease (CVeD) has a remarkable prevalence, with an estimated annual incidence of 2%. It has been demonstrated how the loss of homeostatic mechanisms in the vein wall can take part in the physiopathology of CVeD. In this regard, it has been described how different axis, such as IGF-1/PAPP-A/STC-2 axis, may play an essential role in tissue homeostasis. The aim of this research is to study both genetic and protein expressions of the IGF-1/PAPP-A/STC-2 axis in CVeD patients. It is a cross-sectional study in which genetic (RT-qPCR) and protein (immunohistochemistry) expression analysis techniques were accomplished in saphenous veins from CVeD patients (n = 35) in comparison to individuals without vascular pathology (HV). Results show a significant increase in both genetic and protein expressions of PAPP-A and IGF-1, and a decrement STC-2 expression at the same time in CVeD patients. Our study is a pioneer for demonstrating that the expression of the different components of the IGF-1/PAPP-A/STC-2 axis is altered in CVeD patients. This fact can be a part of the loss of homeostatic mechanisms of the venous tissue. Further research should be destined to deepen into alterations of this axis, as well as to evaluate the usage of these components as therapeutic targets for CVeD. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Update on uveal melanoma: Translational research from biology to clinical practice (Review).
- Author
-
Ortega, Miguel A., Fraile-Martínez, Oscar, García-Honduvilla, Natalio, Coca, Santiago, Álvarez-Mon, Melchor, Buján, Julia, and Teus, Miguel A.
- Published
- 2020
- Full Text
- View/download PDF
20. Pregnancy‐associated venous insufficiency course with placental and systemic oxidative stress.
- Author
-
Ortega, Miguel A., Romero, Beatriz, Asúnsolo, Ángel, Martínez‐Vivero, Clara, Sainz, Felipe, Bravo, Coral, De León‐Luis, Juan, Álvarez‐Mon, Melchor, Buján, Julia, and García‐Honduvilla, Natalio
- Subjects
VENOUS insufficiency ,OXIDATIVE stress ,NITRIC-oxide synthases ,ADP-ribosyltransferases ,ABRUPTIO placentae ,TROPHOBLAST ,PREGNANT women - Abstract
The development of lower extremity venous insufficiency (VI) during pregnancy has been associated with placental damage. VI is associated with increased oxidative stress in venous wall. We have investigated potential disturbance/dysregulation of the production of reactive oxygen species (ROS) in placenta and its eventual systemic effects through the measurement of malondialdehyde (MDA) plasma levels in women with VI. A total of 62 women with VI and 52 healthy controls (HCs) were studied. Levels of nicotinamide adenine dinucleotide phosphate‐oxidase 1 (NOX1), 2 (NOX2), inducible nitric oxide synthase (iNOS), endothelial (eNOS), poly(ADP‐ribose) polymerase PARP (PARP) and ERK were measured in placental tissue with immunohistochemistry and RT‐qPCR. Plasma and placental levels of MDA were determined by colorimetry at the two study times of 32 weeks of gestation and post‐partum. Protein and gene expression levels of NOX1, NOX2, iNOS, PARP and ERK were significantly increased in placentas of VI. eNOS activity was low in both study groups, and there were no significant differences in gene or protein expression levels. Women with VI showed a significant elevation of plasma MDA levels at 32 weeks of gestation, and these levels remained elevated at 32 weeks post‐partum. The MDA levels were significantly higher in placentas of women with VI. Placental damage that was found in the women with VI was characterized by overexpression of oxidative stress markers NOX1, NOX2, and iNOS, as well as PARP and ERK. Pregnant women with VI showed systemic increases in oxidative stress markers such as plasma MDA levels. The foetuses of women with VI had a significant decrease in their venous pH as compared to those from HC women. The situation of oxidative stress and cellular damage created in the placenta is in coexpression with the production of a pH acidification. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. Upregulation of VEGF and PEDF in Placentas of Women with Lower Extremity Venous Insufficiency during Pregnancy and Its Implication in Villous Calcification.
- Author
-
Ortega, Miguel A., Saez, Miguel Ángel, Asúnsolo, Ángel, Romero, Beatriz, Bravo, Coral, Coca, Santiago, Sainz, Felipe, Álvarez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Subjects
CHORIONIC villi ,GENE expression ,IMMUNOHISTOCHEMISTRY ,LEG ,LONGITUDINAL method ,SCIENTIFIC observation ,PLACENTA ,POLYMERASE chain reaction ,PREGNANT women ,RESEARCH ,TRANSFORMING growth factors-beta ,VENOUS insufficiency ,PROTEASE inhibitors ,VASCULAR endothelial growth factors ,REVERSE transcriptase polymerase chain reaction ,CALCINOSIS ,DISEASE complications ,DISEASE risk factors ,PREGNANCY - Abstract
Pregnancy is a period in a woman's life in which changes can occur that affect different physiological processes. Common conditions during this period include vascular changes, such as lower extremity venous insufficiency (VI). This is an observational, analytical, and prospective cohort study in which 114 pregnant women were analyzed, of which 62 were clinically diagnosed with VI. In parallel, 52 control patients without VI (HC) were studied. The aim of this study was to observe changes in angiogenesis and inflammation markers as well as the presence of calcium deposits. The expression of vascular endothelial growth factor (VEGF), transforming growth factor-β (TGF-β), and pigment epithelium-derived factor (PEDF) was analyzed by immunohistochemistry and RT-qPCR. The presence of calcium deposits was revealed using the von Kossa method. In the placentas of mothers with VI, gene expression of VEGF (34.575 [32.380–36.720] VI vs 32.965 [30.580–36.320] HC) and PEDF (25.417 [24.459–27.675] VI vs 24.400 [23.102–30.223] HC) significantly increased, as was protein expression in the placental villi. An increase in calcium deposits was observed in the placentas of women with VI (72.58% VI/53.84% HC). This study revealed the existence of cellular damage in the placental villi of mothers with VI with tissue implications such as increased calcification. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
22. Polylactic‐co‐glycolic acid microspheres added to fixative cements and its role on bone infected architecture.
- Author
-
Ibarra, Blanca, García‐García, Joaquin, Azuara, Galo, Vázquez‐Lasa, Blanca, Ortega, Miguel A., Asúnsolo, Ángel, San Román, Julio, Buján, Julia, García‐Honduvilla, Natalio, and De la Torre, Basilio
- Subjects
MICROSPHERES ,BONE cements ,STAPHYLOCOCCUS aureus infections ,ARTIFICIAL joints ,SILICATE cements (Dentistry) ,BIOMEDICAL materials - Abstract
Joint prostheses are an essential element to improve quality of life. However, prostheses may fail due to several factors, including the most frequent cause, Staphylococcus aureus infection. The identification of new fixing bone cements with less reactivity on bone tissue and an adequate response to infection remains a primary challenge. The aim of this study is to evaluate the response of bone tissue in rabbits after introduction of a hydroxyapatite‐coated titanium rod with a commercial fixative cement (Palacos®) compared to a modified experimental cement (EC) containing polylactic‐co‐glycolic acid (PLGA) microspheres in the presence or absence of contaminating germs. This study used 20 New Zealand rabbits which were divided into four groups (n = 5) depending on the presence or absence of S. aureus and the use of commercial (Palacos®) or EC. A histological method, based on bone architecture damage, was proposed to evaluate from 1 to 9 the histological results and the response of the infected tissue. The macrophage response was also evaluated using monoclonal antibody RAM‐11. The study showed better bone conservation with the use of EC with PLGA microspheres against the Palacos® commercial cement, including the noncontaminated and contaminated groups. © 2019 The Authors. Journal of Biomedical Materials Research Part B: Applied Biomaterials published by Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B:2517–2526, 2019. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
23. Women with Venous Insufficiency in Lower Extremity During Pregnancy Show Damage in Placenta: Evidence of Hypoxia and Oxidative Cellular Stress
- Author
-
Ortega Núñez, Miguel Á., Asúnsolo, Ángel, Álvarez-Rocha, María J., Romero, Beatriz, De León-Luis, Juan, Álvarez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Published
- 2019
- Full Text
- View/download PDF
24. Chronic Treatment with Minoxidil Induces Elastic Fiber Neosynthesis and Functional Improvement in the Aorta of Aged Mice.
- Author
-
Coquand-Gandit, Marion, Jacob, Marie-Paule, Fhayli, Wassim, Romero, Beatriz, Georgieva, Miglena, Bouillot, Stéphanie, Estève, Eric, Andrieu, Jean-Pierre, Brasseur, Sandrine, Bouyon, Sophie, Garcia-Honduvilla, Natalio, Huber, Philippe, Buján, Julia, Atanasova, Milena, Faury, Gilles, Romero Ruiz de la Hermosa, Beatriz, Bouillot, Stéphanie, Estève, Eric, Bujan, Julia, and Buján, Julia
- Published
- 2017
- Full Text
- View/download PDF
25. Patients with Incompetent Valves in Chronic Venous Insufficiency Show Increased Systematic Lipid Peroxidation and Cellular Oxidative Stress Markers.
- Author
-
Ortega, Miguel A., Romero, Beatriz, Asúnsolo, Ángel, Sola, Mayte, Álavrez-Rocha, María J., Sainz, Felipe, Álavrez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Published
- 2019
- Full Text
- View/download PDF
26. Unravelling the Role of MAPKs (ERK1/2) in Venous Reflux in Patients with Chronic Venous Disorder.
- Author
-
Ortega, Miguel A., Asúnsolo, Ángel, Romero, Beatriz, Álvarez-Rocha, María J., Sainz, Felipe, Leal, Javier, Álvarez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Subjects
MANN Whitney U Test ,MITOGEN-activated protein kinases ,VENOUS insufficiency ,GENETIC regulation ,SAPHENOUS vein - Abstract
Chronic venous disorder (CVeD), is a disorder in which there is a modification in the conditions of blood return to the heart. The disorder may arise from incompetent valves and the resultant venous reflux (chronic venous insufficiency, CVI). The economic burden of CVeD on health systems is high, and research efforts have sought to elucidate the mechanisms involved as possible therapeutic targets. The mitogen-activated protein kinase (MAPK) enzymes mediate a wide array of physiopathological processes in human tissues. In this family of proteins, extracellular signal-regulated kinase (ERK)1/2 plays a direct role in the cell homeostasis that determines the viability of mammalian tissues. This study sought to examine whether ERK1/2 plays a role in venous reflux. This was a prospective study performed on 56 participants including 11 healthy controls. Of the CVeD patients, 23 had venous reflux with CVI (CVI-R) and 22 had no reflux (NR). Distribution by age was: controls <50 years (n = 4) and ≥50 years (n = 7); NR <50 years (n = 9) and ≥50 years (n = 13); CVI-R <50 years (n = 11) and ≥50 years (n = 12). Great saphenous vein specimens were subjected to gene (real-time polymerase chain reaction, RT-qPCR) and protein (immunohistochemistry, IHC) expression techniques to identify ERK1/2. Data was compared between groups using the Mann Whitney U test. Patients with CVI showed significant gene activation of ERK1/2 protein, and, in those with venous reflux, the expression of this gene was significantly greater. The CVI-R group <50 years showed significantly greater ERK1/2 gene expression than their age-matched controls. Expression patterns were consistent with IHC findings. Our studies suggest that ERK1/2 expression is involved in venous vascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
27. Improved connective integration of a degradable 3D-nano-apatite/agarose scaffold subcutaneously implanted in a rat model.
- Author
-
García-Honduvilla, Natalio, Coca, Alejandro, Ortega, Miguel A., Trejo, Cynthia, Román, Jesús, Peña, Juan, Cabañas, M. Victoria, Vallet Regi, Maria, and Buján, Julia
- Subjects
APATITE ,AGAROSE ,LABORATORY animals ,GRANULATION tissue ,MASTICATORY muscles ,BONES - Abstract
In this work, we evaluate the tissue response and tolerance to a designed 3D porous scaffold composed of nanocrystalline carbonate-hydroxyapatite and agarose as a preliminary step in bone repair and regeneration. These scaffolds were subcutaneously implanted into rats, which were sacrificed at different times. CD4+, CD8+ and ED1+ cells were evaluated as measurements of inflammatory reaction and tolerance. We observed some inflammatory response early after subcutaneous implantation. The 3D interconnected porosity increased scaffold integration via the formation of granulation tissue and the generation of a fibrous capsule around the scaffold. The capsule is initially formed by collagen which progressively invades the scaffold, creating a network that supports the settlement of connective tissue and generating a compact structure. The timing of the appearance of CD4+ and CD8+ cell populations is in agreement with the resolved inflammatory response. The appearance of macrophage activity evidences a slow and gradual degradation activity. Degradation started with the agarose component of the scaffold, but the nano-apatite was kept intact for up to 30 days. Therefore, this apatite/agarose scaffold showed a high capacity for integration by a connective network that stabilizes the scaffold and results in slow nano-apatite degradation. The fundamental properties of the scaffold would provide mechanical support and facilitate bone mobilization, which is of great importance in the masticatory system or large bones. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
28. Behavior of Smooth Muscle Cells under Hypoxic Conditions: Possible Implications on the Varicose Vein Endothelium.
- Author
-
Ortega, Miguel A., Romero, Beatriz, Asúnsolo, Ángel, Sainz, Felipe, Martinez-Vivero, Clara, Álvarez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Subjects
SAPHENOUS vein ,VARICOSE veins ,HYPOXEMIA ,BIOMARKERS ,VASCULAR surgery ,CELL receptors ,GENE expression ,HOMEOSTASIS ,MUSCLE proteins ,ORGAN donors ,OXIDOREDUCTASES ,POLYMERASE chain reaction ,PROTEIN-tyrosine kinases ,SMOOTH muscle ,TRANSCRIPTION factors ,TRANSFORMING growth factors-beta ,VENOUS insufficiency ,NITRIC-oxide synthases ,VASCULAR endothelial growth factors ,REVERSE transcriptase polymerase chain reaction ,SURGERY - Abstract
Varicose veins are a disease with high incidence and prevalence. In the venous wall, the smooth muscle cells (SMCs) act in the vascular homeostasis that secretes multiple substances in response to stimuli. Any alteration of these cells can modify the function and structure of the other venous layers such as the endothelium, resulting in increases in endothelial permeability and release of substances. Therefore, knowing the cellular and molecular mechanisms of varicose veins is imperative. The aims of this study are to understand how SMCs of patients with varicose veins subjected to saphenectomy of the great saphenous vein react under hypoxic cell conditions and to determine the role of vascular endothelial growth factor (VEGF) in this process. We obtained SMCs from human saphenous vein segments from patients with varicose veins (n=10) and from organ donors (n=6) undergoing surgery. Once expanded, the cells were subjected to hypoxic conditions in specific chambers, and expansion was examined through analyzing morphology and the expression of α-actin. Further gene expression studies of HIF-1α, EGLN3, VEGF, TGF-β1, eNOS, and Tie-2 were performed using RT-qPCR. This study reveals the reaction of venous cells to sustained hypoxia. As significant differential gene expression was observed, we were able to determine how venous cells are sensitive to hypoxia. We hypothesize that venous insufficiency leads to cellular hypoxia with homeostatic imbalance. VEGF plays a differential role that can be related to the cellular quiescence markers in varicose veins, which are possible therapeutic targets. Our results show how SMCs are sensitive to hypoxia with a different gene expression. Therefore, we can assume that the condition of venous insufficiency leads to a situation of sustained cellular hypoxia. This situation may explain the cellular response that occurs in the venous wall as a compensatory mechanism. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
29. Increase and Redistribution of Sex Hormone Receptors in Premenopausal Women Are Associated with Varicose Vein Remodelling.
- Author
-
García-Honduvilla, Natalio, Asúnsolo, Ángel, Ortega, Miguel A., Sainz, Felipe, Leal, Javier, Lopez-Hervas, Pedro, Pascual, Gemma, and Buján, Julia
- Published
- 2018
- Full Text
- View/download PDF
30. Implication of the PI3K/Akt/mTOR Pathway in the Process of Incompetent Valves in Patients with Chronic Venous Insufficiency and the Relationship with Aging.
- Author
-
Ortega, Miguel A., Asúnsolo, Ángel, Leal, Javier, Romero, Beatriz, Alvarez-Rocha, María J., Sainz, Felipe, Álvarez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Published
- 2018
- Full Text
- View/download PDF
31. A Novel Model of Human Skin Pressure Ulcers in Mice.
- Author
-
Maldonado, Andrés A., Cristóbal, Lara, Martín-López, Javier, Mallén, Mar, García-Honduvilla, Natalio, and Buján, Julia
- Subjects
SKIN diseases ,ULCERS ,IMMUNODEFICIENCY ,LABORATORY mice ,HISTOLOGY ,SKIN grafting - Abstract
Introduction: Pressure ulcers are a prevalent health problem in today's society. The shortage of suitable animal models limits our understanding and our ability to develop new therapies. This study aims to report on the development of a novel and reproducible human skin pressure ulcer model in mice. Material and Methods: Male non-obese, diabetic, severe combined immunodeficiency mice (n = 22) were engrafted with human skin. A full-thickness skin graft was placed onto 4×3 cm wounds created on the dorsal skin of the mice. Two groups with permanent grafts were studied after 60 days. The control group (n = 6) was focused on the process of engraftment. Evaluations were conducted with photographic assessment, histological analysis and fluorescence in situ hybridization (FISH) techniques. The pressure ulcer group (n = 12) was created using a compression device. A pressure of 150 mmHg for 8 h, with a total of three cycles of compression-release was exerted. Evaluations were conducted with photographic assessment and histological analysis. Results: Skin grafts in the control group took successfully, as shown by visual assessment, FISH techniques and histological analysis. Pressure ulcers in the second group showed full-thickness skin loss with damage and necrosis of all the epidermal and dermal layers (ulcer stage III) in all cases. Complete repair occurred after 40 days. Conclusions: An inexpensive, reproducible human skin pressure ulcer model has been developed. This novel model will facilitate the development of new clinically relevant therapeutic strategies that can be tested directly on human skin. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
32. Modification of the Polymer of a Bone Cement with Biodegradable Microspheres of PLGA and Loading with Daptomycin and Vancomycin Improve the Response to Bone Tissue Infection.
- Author
-
García-García, Joaquin, Azuara, Galo, Fraile-Martinez, Oscar, García-Montero, Cielo, Álvarez-Mon, Miguel Angel, Ruíz-Díez, Sara, Álvarez-Mon, Melchor, Buján, Julia, García-Honduvilla, Natalio, Ortega, Miguel A., and De la Torre, Basilio
- Subjects
BONE cements ,LINEZOLID ,DAPTOMYCIN ,VANCOMYCIN ,POLYMERS ,MICROSPHERES ,BIODEGRADABLE materials ,CEMENT - Abstract
Chronic infections are one of the most serious adverse outcomes of prosthetic surgery. Prosthetic revision surgery using a bone cement loaded with antibiotics between the two stages of the surgery is commonly performed. However, this method often fails to reach the minimum inhibitory concentration and promotes antibiotic resistance, thus emphasizing the need for improving the current available therapies. Materials and methods: In this study, we performed a study of the in vivo response of a polymer-based construct of poly (lactic-co-glycolic acid) (PLGA) in the solid phase of Palacos R
® in combination with vancomycin, daptomycin, and/or linezolid. To test its effectiveness, we applied an in vivo model, using both histological and immunohistochemical analyses to study the bone tissue. Results: The presence of PLGA in the combination of vancomycin with daptomycin showed the most promising results regarding the preservation of bone cytoarchitecture and S. aureus elimination. Conversely, the combination of vancomycin plus linezolid was associated with a loss of bone cytoarchitecture, probably related to an increased macrophage response and inefficient antimicrobial activity. Conclusions: The modification of Palacos R® bone cement with PLGA microspheres and its doping with the antibiotic daptomycin in combination with vancomycin improve the tissue response to bone infection. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
33. Chronic Venous Disease in Pregnant Women Causes an Increase in ILK in the Placental Villi Associated with a Decrease in E-Cadherin.
- Author
-
Ortega, Miguel A., Chaowen, Chen, Fraile-Martinez, Oscar, García-Montero, Cielo, Saez, Miguel A., Cruza, Iris, Pereda-Cerquella, Claude, Alvarez-Mon, Miguel Angel, Guijarro, Luis G., Fatych, Yuliia, Menor-Salván, César, Alvarez-Mon, Melchor, De Leon-Luis, Juan, Buján, Julia, Garcia-Honduvilla, Natalio, Bravo, Coral, and Asúnsolo-del-Barco, Angel
- Subjects
CHORIONIC villi ,PREGNANCY complications ,CADHERINS ,CHRONIC diseases ,EXTRACELLULAR matrix - Abstract
Chronic venous disease (CVD) is a multifactorial vascular disorder frequently manifested in lower limbs in the form of varicose veins (VVs). Women are a vulnerable population for suffering from CVD, especially during pregnancy, when a plethora of changes occur in their cardiovascular system. Previous studies have indicated a worrisome association between CVD in pregnancy with the placental structure and function. Findings include an altered cellular behavior and extracellular matrix (ECM) composition. Integrin-linked kinase (ILK) is a critical molecule involved in multiple physiological and pathological conditions, and together with cadherins, is essential to mediate cell to ECM and cell to cell interplay, respectively. Thus, the aim of this study was to evaluate the implication of ILK and a set of cadherins (e-cadherin, cadherin-6 and cadherin-17) in placentas of women with CVD in order to unravel the possible pathophysiological role of these components. Gene expression (RT-qPCR) and protein expression (immunohistochemistry) studies were performed. Our results show a significant increase in the gene and protein expression of ILK, cadherin-6 and cadherin-17 and a decrease of e-cadherin in the placenta of women with CVD. Overall, this work shows that an abnormal expression of ILK, e-cadherin, cadherin-6 and cadherin-17 may be implicated in the pathological changes occurring in the placental tissue. Further studies should be conducted to determine the possible associations of these changes with maternal and fetal well-being. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. The Role of the Stromal Extracellular Matrix in the Development of Pterygium Pathology: An Update.
- Author
-
Martín-López, Javier, Pérez-Rico, Consuelo, Benito-Martínez, Selma, Pérez-Köhler, Bárbara, Buján, Julia, and Pascual, Gemma
- Subjects
LYSYL oxidase ,PTERYGIUM ,EXTRACELLULAR matrix ,INFLAMMATORY mediators ,GENETIC overexpression ,EXOSTOSIS - Abstract
Pterygium is a benign fibrovascular lesion of the bulbar conjunctiva with frequent involvement of the corneal limbus. Its pathogenesis has been mainly attributed to sun exposure to ultraviolet-B radiation. Obtained evidence has shown that it is a complex and multifactorial process which involves multiple mechanisms such as oxidative stress, dysregulation of cell cycle checkpoints, induction of inflammatory mediators and growth factors, angiogenic stimulation, extracellular matrix (ECM) disorders, and, most likely, viruses and hereditary changes. In this review, we aim to collect all authors' experiences and our own, with respect to the study of fibroelastic ECM of pterygium. Collagen and elastin are intrinsic indicators of physiological and pathological states. Here, we focus on an in-depth analysis of collagen (types I and III), as well as the main constituents of elastic fibers (tropoelastin (TE), fibrillins (FBNs), and fibulins (FBLNs)) and the enzymes (lysyl oxidases (LOXs)) that carry out their assembly or crosslinking. All the studies established that changes in the fibroelastic ECM occur in pterygium, based on the following facts: An increase in the synthesis and deposition of an immature form of collagen type III, which showed the process of tissue remodeling. An increase in protein levels in most of the constituents necessary for the development of elastic fibers, except FBLN4, whose biological roles are critical in the binding of the enzyme LOX, as well as FBN1 for the development of stable elastin. There was gene overexpression of TE, FBN1, FBLN5, and LOXL1, while the expression of LOX and FBLN2 and -4 remained stable. In conclusion, collagen and elastin, as well as several constituents involved in elastic fiber assembly are overexpressed in human pterygium, thus, supporting the hypothesis that there is dysregulation in the synthesis and crosslinking of the fibroelastic component, constituting an important pathogenetic mechanism for the development of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives.
- Author
-
Pekarek, Leonel, Fraile-Martinez, Oscar, Garcia-Montero, Cielo, Alvarez-Mon, Miguel A., Acero, Julio, Ruiz-Llorente, Lidia, García-Honduvilla, Natalio, Albillos, Agustin, Buján, Julia, Alvarez-Mon, Melchor, Guijarro, Luis G., and Ortega, Miguel A.
- Subjects
PANCREATIC tumors ,TREATMENT effectiveness ,DIAGNOSIS ,PROGNOSIS ,THERAPEUTICS ,PANCREATIC cancer - Abstract
Pancreatic cancer has a dire prognosis and will represent the second leading cause of cancer death in the next 10 years. The multifactorial approach represents one of the main issues in controlling the extension of this neoplasm. In recent years, the characteristics of the tumor microenvironment, metastasis mechanisms and the relationship between immune system and neoplastic cells have been described, which has made it possible to understand the pathophysiology of pancreatic adenocarcinoma. Currently, there is a failure to provide an effective preventive method or early detection, so patients present with an advanced stage at the time of diagnosis. Despite numerous efforts, little progress has been made in clinical outcome and in improving survival in long term. Therefore, in the recent years, diverse diagnostic tests, treatments and possible approaches have been developed in the fields of radiotherapy, chemotherapy and surgery to find a combination of them that improves life expectancy in patients diagnosed with pancreatic cancer. At the moment, numerous clinical trials are being conducted to evaluate preventive diagnostic procedures such as serological markers or perfecting available imaging tests. On the other hand, implementation of immunotherapy is being studied in a neoplasm that has lagged in the application of this procedure since present possible treatments do not substantially improve quality of life. Therefore, the purpose of our study is to summarize the main progresses that have been made in the diagnosis, treatment and screening of this disease, explaining the limitations that have been observed and analyzing future prospects in the management of this illness. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
36. An increase in elastogenic components in the placental villi of women with chronic venous disease during pregnancy is associated with decreased EGFL7 expression level.
- Author
-
Ortega, Miguel A., Asúnsolo, Ángel, Fraile-Martínez, Oscar, Sainz, Felipe, Saez, Miguel A., Bravo, Coral, De León-Luis, Juan A., Alvarez-Mon, Miguel A., Coca, Santiago, Álvarez-Mon, Melchor, Buján, Julia, and García-Honduvilla, Natalio
- Subjects
CHORIONIC villi ,THIRD trimester of pregnancy ,CHRONIC diseases ,LYSYL oxidase ,PROTEIN expression ,PLACENTA diseases ,SECOND trimester of pregnancy - Abstract
Chronic venous disease (CVD) is the response to a series of hemodynamic changes in the venous system and the onset of this disease is often triggered by pregnancy. Placental tissue is particularly sensitive to the characteristic changes which occurs in venous hypertension. In this regard, changes in the extracellular matrix (ECM), that occur to adapt to this situation, are fundamental to controlling elastogenesis. Therefore, the aim of the present study was to analyze the changes that occur in the mRNA and protein expression level of proteins related to elastogenesis in the placental villi of women diagnosed with CVD, in the third trimester of pregnancy. An observational, analytical and prospective cohort study was conducted, in which the placenta from 62 women with CVD were compared with that in placenta from 52 women without a diagnosis of CVD. Gene and protein expression levels were analyzed using reverse transcription-quantitative PCR and immunohistochemistry, respectively. The results showed a significant decrease in the gene and protein expression level of EGFL7 in the placental villi of women with CVD. By contrast, significant increases in the gene and protein expression level of ECM-related proteins, such as tropoelastin, fibulin 4, fibrillin 1 and members of the lysyl oxidase family (LOX and LOXL-1) were also found in the placental villi of women with CVD. To the best of our knowledge, the results from the present study showed for the first time that CVD during pregnancy was associated with changes in the mRNA and protein expression level in essential components of the EGFL7-modulated elastogenesis process in placental villi. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. Wear Risk Prevention and Reduction in Total Hip Arthroplasty. A Personalized Study Comparing Cement and Cementless Fixation Techniques Employing Finite Element Analysis.
- Author
-
González-Bravo, Carlos, Ortega, Miguel A., Buján, Julia, Torre, Basilio de la, and Barrios, Loreto
- Subjects
TOTAL hip replacement ,FINITE element method ,CEMENT ,BONE resorption ,MOLECULAR weights - Abstract
The wear rate on Total Hip Arthroplasty (THA) entails a heavy burden for patients. This becomes more relevant with increased wear risk and its consequences such as osteolysis. In addition, osteolysis has been described in cemented and uncemented acetabular implants, and nowadays, controversy remains as to whether or not to cement the acetabular component. A personalized theoretical study was carried out to investigate which parameters have an influence on wear risk and to determine the best fixation method. Liner wear risk was assessed for two different types of fixation (cemented vs uncemented) through Finite Elements Analysis (FEA). The intraoperative variables used to determine the wear risk (cervical-diaphyseal angle, Center of Rotation positioning -COR-, head material, head size, and liner thickness) are vital parameters in surgical planning. Two types of tridimensional liner models of Ultra High Molecular Weight Polyethene (UHMWPE) were simulated through finite element analysis (FEA—over 216 cases were the core of this research). A significant relationship was found between the cervical-diaphyseal angle and wear risk (p < 0.0001), especially in valgus morphology. The acetabular fixation technique (p < 0.0001) and liner thickness (p < 0.0001) showed a significant relationship with wear risk. According to our study, using a cemented fixation with a thick liner in the right center of rotation appears to be the proper stratagy for preventing polyethylene liner wear. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. Risk Factors in Third and Fourth Degree Perineal Tears in Women in a Tertiary Centre: An Observational Ambispective Cohort Study.
- Author
-
Barca, Juan A., Bravo, Coral, Pintado-Recarte, Maria P., Cueto-Hernández, Ignacio, Ruiz-Labarta, Javier, Cuñarro, Yolanda, Buján, Julia, Alvarez-Mon, Melchor, Ortega, Miguel A., and De León-Luis, Juan A.
- Subjects
BIRTH weight ,PERINEUM ,HOSPITAL maternity services ,CESAREAN section ,COHORT analysis ,INDUCED labor (Obstetrics) ,NEWBORN infants ,LABOR (Obstetrics) - Abstract
Objectives: To analyze the main risk factors associated with third and fourth degree postpartum perineal tears in women attended to in our obstetrics service. Methods: An observational, retrospective, hospital cohort study was carried out in women whose deliveries were attended to in the obstetrics service of the Hospital General Universitario Gregorio Marañón de Madrid (HGUGM), during the period from January 2010 to April 2017. Results: During the study period, a total of 33,026 patients were included in the study. For maternal variables, the associated increased risk of severe perineal tearing in nulliparous women is OR = 3.48, for induced labor OR = 1.29, and for instrumental delivery by forceps OR = 4.52 or spatulas OR = 4.35; for the obstetric variable of episiotomy, it is OR = 3.41. For the neonatal variables, the weight of the newborns has a directly proportional relationship with the risk of severe tears, and for birth weights of 3000 g (OR = 2.41), 3500 g (OR = 1.97), and 4000 g (OR = 2.17), statistically significant differences were found in each of the groups (p < 0.05). Conclusion: Primiparity, induction of labor, episiotomy, instrumental delivery with forceps or spatula, and a birth weight of 3000 g or more are significantly associated with an increased risk of third and fourth degree perineal tears. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Influence of Psychological Distress in Patients with Hypoallergenic Total Knee Arthroplasty. Treatment Algorithm for Patients with Metal Allergy and Knee Osteoarthritis.
- Author
-
Peña, Pilar, Ortega, Miguel A., Buján, Julia, and De la Torre, Basilio
- Published
- 2021
- Full Text
- View/download PDF
40. Pelvic Floor Morbidity Following Vaginal Delivery versus Cesarean Delivery: Systematic Review and Meta-Analysis.
- Author
-
Barca, Juan A., Bravo, Coral, Pintado-Recarte, Maria P., Asúnsolo, Ángel, Cueto-Hernández, Ignacio, Ruiz-Labarta, Javier, Buján, Julia, Ortega, Miguel A., and De León-Luis, Juan A.
- Subjects
PELVIC floor ,CESAREAN section ,URINARY incontinence ,MEDICAL subject headings ,PELVIC organ prolapse - Abstract
Objective: To compare pelvic floor disorders between vaginal delivery (VD) and cesarean delivery (CD). Methods: For this study, a PUBMED database search was used, utilizing a combination of relevant medical subjects' headings (MeSH) terms, with the following keywords: "Pelvic floor disorders" or "Pelvic floor morbidity" and "Delivery". Search limits were articles in English or Spanish, about women, published from December 2009 to December 2019. The STATA 16 package was used for meta-analysis and data heterogeneity assessment. Results: Thirteen studies meeting eligibility criteria were identified comprising 1,597,303 participants. Abstract: Pelvic floor morbidity prevalence was Urinary Incontinence (UI) 27.9% (5411 patients in 7 studies with reported cases), Pelvic Organ Prolapse (POP) 14.2% (6019 patients in 8 studies with reported cases), and Anal Incontinence (AI) 0.4% (1,589,740 patients in 5 studies with reported cases). Our meta-analyses revealed significantly higher rates of all three morbidities and overall morbidity in the VD versus CD group: UI OR = 2.17, 95% CI 1.64–2.87, p for heterogeneity ≤ 0.0001, I
2 = 84%; POP OR = 3.28, 95% CI 1.91–5.63, p for heterogenicity ≤ 0.043, I2 = 63%; AI OR = 1.53, 95% CI 1.32–1.77; p for heterogeneity ≤ 0.291, I2 = 20%; and overall morbidity (OR = 2.17, 95% CI 1.64–2.87; p for heterogeneity ≤ 0.0001, I2 = 84%). Conclusion: Vaginal delivery is directly related to the appearance of pelvic floor disorders, mainly UI, POP, and AI. The risk of POP should be taken into higher consideration after vaginal delivery and postpartum follow-up should be performed, to identify and/or treat it at the earliest stages. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
41. Physical Activity as an Imperative Support in Breast Cancer Management.
- Author
-
Ortega, Miguel A., Fraile-Martínez, Oscar, García-Montero, Cielo, Pekarek, Leonel, Guijarro, Luis G., Castellanos, Alejandro J., Sanchez-Trujillo, Lara, García-Honduvilla, Natalio, Álvarez-Mon, Melchor, Buján, Julia, Zapico, Álvaro, Lahera, Guillermo, and Álvarez-Mon, Miguel A.
- Subjects
BREAST cancer prognosis ,BREAST tumor prevention ,SURVIVAL ,LIFESTYLES ,PHYSICAL activity ,CANCER patients ,QUALITY of life ,HEALTH behavior ,COMBINED modality therapy ,DISEASE management ,EXERCISE therapy - Abstract
Simple Summary: During the recent years, the field of exercise and physical activity have expanded prominently, not only for the prevention but also for the management of different pathologies, including breast cancer. A broad range of studies have been conducted to analyze this relationship, in aim to find the best routines and use of exercise in breast cancer management. Although many works provide contradictory results in these terms, there is less doubt regarding the role of physical activity as a central support for breast cancer patients, due to the systemic benefits of exercise in these women, therefore decreasing the risk of breast cancer-related complications and increasing their quality of life and survival. Future research should be established in order to individualize the physical activity performed by these women based on the available scientific evidence in a multidisciplinary context to maximize the success of breast cancer management. Breast cancer (BC) is the most common malignancy and the second cause of cancer-related death among women. It is estimated that 9 in 10 cases of BC are due to non-genetic factors, and approximately 25% to 30% of total breast cancer cases should be preventable only by lifestyle interventions. In this context, physical activity represents an excellent and accessible approach not only for the prevention, but also for being a potential support in the management of breast cancer. The present review will collect the current knowledge of physical activity in the background of breast cancer, exploring its systemic and molecular effects, considering important variables in the training of these women and the evidence regarding the benefits of exercise on breast cancer survival and prognosis. We will also summarize the various effects of physical activity as a co-adjuvant therapy in women receiving different treatments to deal with its adverse effects. Finally, we will reveal the impact of physical activity in the enhancement of quality of life of these patients, to conclude the central role that exercise must occupy in breast cancer management, in an adequate context of a healthy lifestyle. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. Decrease of Quality of Life, Functional Assessment and Associated Psychological Distress in Patients with Hypoallergenic Total Knee Arthroplasty.
- Author
-
Peña, Pilar, Ortega, Miguel A., Buján, Julia, and De la Torre, Basilio
- Subjects
TOTAL knee replacement ,PSYCHOLOGICAL distress ,FUNCTIONAL assessment ,PSYCHOLOGICAL tests ,PROPENSITY score matching ,DENTAL ceramic metals - Abstract
Total knee arthroplasty (TKA) is the final treatment for knee osteoarthritis, and 15–30% of patients show little or no improvement. This high percentage is related to aspects of the surgical technique, the selected implant, and specific patient characteristics. The aim of this study was to analyze whether there are differences in quality of life (QoL) and functional capacity among patients undergoing TKA with conventional implants compared to those treated with hypoallergenic oxinium implants. A pragmatic clinical study was carried out that included patients who underwent TKA between January 2013 and December 2015. During this period, 245 knees in 228 patients were treated. Eleven patients were excluded, leaving a sample of 161 conventionally treated knees, 72 knees treated with hypoallergenic implants, and one patient who received both implant types. In all patients, QoL and functional capacity were measured with the WOMAC index, the SF-12 questionnaire, and the Euro-Qol-5D L-VAS. We also assessed the psychological distress of each patient and related the findings to the functional results. The differences in QoL were tested using ANCOVA and propensity score matching (PSM) models adjusted for sex, age, weight, psychiatric history and associated complications. Patients who underwent TKA using conventional prostheses had significantly better scores on the total WOMAC index and in the pain domain (p < 0.05) than those who received hypoallergenic prostheses, but no significant differences were observed for the other domains in the ANCOVA. In contrast, with the PSM, we also found statistically significant differences in the difficulty domain of the WOMAC. Significant differences were found for the SF-12 mental health questionnaire results (p = 0.038), but the same did not occur for the physical health domain in the ANCOVA and PSM. We also found statistically significant differences in the Euro-Qol-5D index results (p = 0.041), but not in the VAS scale scores for the same questionnaire in the ANCOVA, and we did not find significant differences in either with the PSM. Patients with metal allergies and those who present psychological distress had WOMAC, SF-12, and Euro-Qol-5D results that were statistically significantly worse than those of patients who received conventional implants. Patients who underwent hypoallergic TKA had lower scores on the QoL and functional capacity scales than patients who received conventional Cr–Co implants. Additionally, patients with psychological distress had worse results on the questionnaires, and those with a metal allergy had even lower scores; the differences were statistically significant. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
43. The Regulatory Role of Mitochondrial MicroRNAs (MitomiRs) in Breast Cancer: Translational Implications Present and Future.
- Author
-
Ortega, Miguel A., Fraile-Martínez, Oscar, Guijarro, Luis G., Casanova, Carlos, Coca, Santiago, Álvarez-Mon, Melchor, Buján, Julia, García-Honduvilla, Natalio, and Asúnsolo, Ángel
- Subjects
BREAST tumor treatment ,BREAST tumors ,GENE expression ,TUMOR markers ,MITOCHONDRIAL RNA ,MICRORNA - Abstract
Simple Summary: Mitochondrial microRNAs (mitomiRs) are an emerging field of study in a wide range of tumours including breast cancer. By targeting mitochondrial, or non-mitochondrial products, mitomiRs are able to regulate the functions of this organelle, thus controlling multiple carcinogenic processes. The knowledge of this system may provide a novel approach for targeted therapies, as potential biomarkers or helping in the diagnosis of such a complex malignancy. Breast cancer is the most prevalent and incident female neoplasm worldwide. Although survival rates have considerably improved, it is still the leading cause of cancer-related mortality in women. MicroRNAs are small non-coding RNA molecules that regulate the posttranscriptional expression of a wide variety of genes. Although it is usually located in the cytoplasm, several studies have detected a regulatory role of microRNAs in other cell compartments such as the nucleus or mitochondrion, known as "mitomiRs". MitomiRs are essential modulators of mitochondrion tasks and their abnormal expression has been linked to the aetiology of several human diseases related to mitochondrial dysfunction, including breast cancer. This review aims to examine basic knowledge of the role of mitomiRs in breast cancer and discusses their prospects as biomarkers or therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
44. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications.
- Author
-
Ortega, Miguel A., Fraile-Martínez, Oscar, Naya, Irene, García-Honduvilla, Natalio, Álvarez-Mon, Melchor, Buján, Julia, Asúnsolo, Ángel, and de la Torre, Basilio
- Abstract
Obesity is a condition of rising prevalence worldwide, with important socioeconomic implications, being considered as a growing public health concern. Frequently, obesity brings other complications in addition to itself—like Type 2 Diabetes Mellitus (T2DM)—sharing origin, risk factors and pathophysiological mechanisms. In this context, some authors have decided to include both conditions as a unique entity known as "diabesity". In fact, understanding diabesity as a single disease is possible to maximise the benefits from therapies received in these patients. Gut microbiota plays a key role in individual's health, and their alterations, either in its composition or derived products are related to a wide range of metabolic disorders like T2DM and obesity. The present work aims to collect the different changes reported in gut microbiota in patients with T2DM associated with obesity and their possible role in the onset, development, and establishment of the disease. Moreover, current research lines to modulate gut microbiota and the potential clinical translation derived from the knowledge of this system will also be reviewed, which may provide support for a better clinical management of such a complex condition. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
45. Dendrimers and Dendritic Materials: From Laboratory to Medical Practice in Infectious Diseases.
- Author
-
Ortega, Miguel Ángel, Guzmán Merino, Alberto, Fraile-Martínez, Oscar, Recio-Ruiz, Judith, Pekarek, Leonel, G. Guijarro, Luis, García-Honduvilla, Natalio, Álvarez-Mon, Melchor, Buján, Julia, and García-Gallego, Sandra
- Subjects
COMMUNICABLE diseases ,MEDICAL practice ,DENDRIMERS ,MEDICAL laboratories ,GENE transfection - Abstract
Infectious diseases are one of the main global public health risks, predominantly caused by viruses, bacteria, fungi, and parasites. The control of infections is founded on three main pillars: prevention, treatment, and diagnosis. However, the appearance of microbial resistance has challenged traditional strategies and demands new approaches. Dendrimers are a type of polymeric nanoparticles whose nanometric size, multivalency, biocompatibility, and structural perfection offer boundless possibilities in multiple biomedical applications. This review provides the reader a general overview about the uses of dendrimers and dendritic materials in the treatment, prevention, and diagnosis of highly prevalent infectious diseases, and their advantages compared to traditional approaches. Examples of dendrimers as antimicrobial agents per se, as nanocarriers of antimicrobial drugs, as well as their uses in gene transfection, in vaccines or as contrast agents in imaging assays are presented. Despite the need to address some challenges in order to be used in the clinic, dendritic materials appear as an innovative tool with a brilliant future ahead in the clinical management of infectious diseases and many other health issues. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
46. Increased Angiogenesis and Lymphangiogenesis in the Placental Villi of Women with Chronic Venous Disease during Pregnancy.
- Author
-
Ortega, Miguel A, Saez, Miguel A, Fraile-Martínez, Oscar, Asúnsolo, Ángel, Pekarek, Leonel, Bravo, Coral, Coca, Santiago, Sainz, Felipe, Mon, Melchor Álvarez-, Buján, Julia, and García-Honduvilla, Natalio
- Subjects
PLACENTAL growth factor ,THIRD trimester of pregnancy ,CHRONIC diseases ,CHORIONIC villi ,ABRUPTIO placentae ,NEOVASCULARIZATION ,POLYMERASE chain reaction - Abstract
Pregnancy is a period in a woman's life associated with an increased risk of developing lower extremity chronic venous disease (CVD). Pregnancy-associated CVD is associated with changes in placental villi. We investigated angiogenesis and lymphangiogenesis in the placental villi of women with CVD during pregnancy compared with healthy controls with no history of CVD (HC). An observational, analytical, and prospective cohort study was conducted on 114 women in their third trimester of pregnancy (32 weeks). Sixty-two participants were clinically diagnosed with CVD. In parallel, 52 controls with no history of CVD (HC) were studied. Gene and protein expression of CD31, podoplanin (D2-40), Flt-1, and placental growth factor (PIGF) was analysed by real-time polymerase chain reaction (RT-qPCR) and immunohistochemistry. CD31 and D2-40 gene expression was significantly greater in the placental villi of women with CVD, as were the numbers of vessels positive for CD31 and D2-40. Significantly higher gene and protein expression of Flt-1 and PIGF was observed in the placental villi of women with CVD. Histological analysis showed more placental villi with periodic acid of Schiff (PAS)-positive material in women with CVD. Our results show a connection between pregnancy-associated CVD and leading to higher proangiogenic and lymphangiogenic activity in placental villi. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
47. Local Growth Hormone Therapy for Pressure Ulcer Healing on a Human Skin Mouse Model.
- Author
-
Cristóbal, Lara, de los Reyes, Nerea, Ortega, Miguel A., Álvarez-Mon, Melchor, García-Honduvilla, Natalio, Buján, Julia, and Maldonado, Andrés A.
- Abstract
The growth hormone is involved in skin homeostasis and wound healing. We hypothesize whether it is possible to improve pressure ulcer (PU) healing by locally applying the recombinant human growth hormone (rhGH) in a human skin mouse model. Non-obese diabetic/severe combined immunodeficient mice (n = 10) were engrafted with a full-thickness human skin graft. After 60 days with stable grafts, human skin underwent three cycles of ischemia-reperfusion with a compression device to create a PU. Mice were classified into two groups: rhGH treatment group (n = 5) and control group (n = 5). In the rhGH group for local intradermal injections, each had 0.15 mg (0.5IU) applied to the PU edges, once per week for four weeks. Evaluation of the wound healing was conducted with photographic and visual assessments, and histological analysis was performed after complete wound healing. The results showed a healing rate twice as fast in the rhGH group compared to the control group (1.25 ± 0.33 mm2/day versus 0.61 ± 0.27 mm2/day; p-value < 0.05), with a faster healing rate during the first 30 days. The rhGH group showed thicker skin (1953 ± 457 µm versus 1060 ± 208 µm; p-value < 0.05) in the repaired area, with a significant decrease in collagen type I/III ratio at wound closure (62 days, range 60–70). Local administration of the rhGH accelerates PU healing in our model. The rhGH may have a clinical use in pressure ulcer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
48. Bioceramic versus traditional biomaterials for endodontic sealers according to the ideal properties.
- Author
-
Ortega MA, Rios L, Fraile-Martinez O, Liviu Boaru D, De Leon-Oliva D, Barrena-Blázquez S, Pereda-Cerquella C, Garrido-Gil MJ, Manteca L, Buján J, García-Honduvilla N, García-Montero C, and Rios-Parra A
- Subjects
- Humans, Materials Testing, Epoxy Resins chemistry, Zinc Oxide-Eugenol Cement, Biocompatible Materials, Root Canal Filling Materials chemistry
- Abstract
Odontology, as a scientific discipline, continuously collaborates with biomaterials engineering to enhance treatment characteristics and patients' satisfaction. Endodontics, a specialized field of dentistry, focuses on the study, diagnosis, prevention, and treatment of dental disorders affecting the dental pulp, root, and surrounding tissues. A critical aspect of endodontic treatment involves the careful selection of an appropriate endodontic sealer for clinical use, as it significantly influences treatment outcomes. Traditional sealers, such as zinc oxide-eugenol, fatty acid, salicylate, epoxy resin, silicone, and methacrylate resin systems, have been extensively used for decades. However, advancements in endodontics have given rise to bioceramic-based sealers, offering improved properties and addressing new challenges in endodontic therapy. In this review, a classification of these materials and their ideal properties are presented to provide evidence-based guidance to clinicians. Physicochemical properties, including sealing ability, stability over time and space, as well as biological properties such as biocompatibility and antibacterial characteristics, along with cost-effectiveness, are essential factors influencing clinicians' decisions based on individual patient evaluations., (©The Author(s) 2024. Open Access. This article is licensed under a Creative Commons CC-BY International License.)
- Published
- 2024
- Full Text
- View/download PDF
49. Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3.
- Author
-
Fraile-Martinez O, García-Montero C, Pekarek L, Saz JV, Álvarez-Mon MÁ, Barrena-Blázquez S, García-Honduvilla N, Buján J, Asúnsolo Á, Coca S, Alvarez-Mon M, Guijarro LG, Saez MA, and Ortega MA
- Subjects
- Humans, Biomarkers, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Prognosis, Inflammasomes metabolism, Pancreatic Neoplasms pathology
- Abstract
Pancreatic cancer is a malignant neoplasm that, despite its low frequency, has a 5-year survival rate of less than 10%. The study of different histopathological markers has allowed a better understanding of the onset and development of this type of tumor as well as facilitating an approach to clinical variables based on their diagnostic, prognostic, and predictive value. In this sense, the NLRP3 protein of the inflammasome has been shown to be a component of great relevance in the initiation and progression of pancreatic cancer, although the value of this biomarker in patients has not yet been clarified. In this study, we selected 41 patients with pancreatic cancer and followed them for 60 months (5 years), evaluating their NLRP3 expression using immunohistochemical techniques. Furthermore, by performing Kaplan-Meier curves, we evaluated the survival of these patients in relation to their NLRP3 expression. Our results show that a significant percentage of our cohort had high expression of this component (90.74%) and that there is an inverse relationship between the expression of NLRP3 and patient survival. High levels of NLRP3 expression are related to lower survival and worse prognosis in these patients, possibly due to an ineffective immune system response and increased tumor-promoted inflammation. Future studies should be aimed at confirming these results in larger groups and evaluating various clinical strategies based on this knowledge., (©The Author(s) 2024. Open Access. This article is licensed under a Creative Commons CC-BY International License.)
- Published
- 2024
- Full Text
- View/download PDF
50. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer.
- Author
-
Ortega MA, Pekarek L, Garcia-Montero C, Fraile-Martinez O, Saez MA, Asúnsolo A, Alvarez-Mon MA, Monserrat J, Coca S, Toledo-Lobo MV, García-Honduvilla N, Albillos A, Buján J, Alvarez-Mon M, and Guijarro LG
- Subjects
- Humans, Immunohistochemistry, Neoplasm Staging, Prognosis, Survival Rate, Pancreatic Neoplasms, Pancreatic Neoplasms pathology
- Abstract
Pancreatic cancer is a malignancy of rising incidence, especially in developed countries due to causes such as sedentary lifestyles, tobacco smoking and ultraprocessed high fat and high sugar diets, amongst others. It is in fact the 7th cause of cancer-related deaths worldwide, and, in the following years, it is expected to climb upwards to 2nd position, after lung cancer. This is because it may have an asymptomatic course, and when it becomes evident it is in advanced stages, accompanied by metastasis generally. For this reason, survival rates are so low and, even in the few successful cases there is a high possibility of recurrence. Identifying new molecular biomarkers is arising as a highly useful tool for pancreatic cancer clinical management, although much research and work remain to be done in this field. Thus, the present study aims to analyze a series of molecules (IRS-4, Rb1, Ki-67 y COX-2) as candidates for prognosis and survival by immunohistochemistry techniques. Additionally, a 60-month longitudinal surveillance program was conducted, associated with diverse clinical parameters. Kaplan-Meier curves estimating the time of survival according to tumoral expression of those molecules denoted a low cumulative survival rate. Importantly, we observed that high levels of IRS-4 were significantly associated with a bad prognosis of the disease, increasing 160 times the mortality risk. In this way, our research showed a relevant value of these biomarkers in pancreatic cancer patients' survival, opening a pathway for future research areas designed to inhibit these components.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.